alpha-aminopyridine has been researched along with albuterol in 22 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (9.09) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (13.64) | 29.6817 |
| 2010's | 17 (77.27) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bijak, A; Czołpiński, T | 1 |
| Bayliss, J; Canepa-Anson, R; Dawson, JR; Kuan, P; Norell, MS; Poole-Wilson, PA; Reuben, S; Sutton, GC | 1 |
| Bach, T; Candelore, MR; Cascieri, MA; Cioffe, C; Deng, L; Fisher, MH; Forrest, MJ; Hegarty-Friscino, B; Hom, G; MacIntyre, E; Marko, O; Ok, HO; Strader, C; Szumiloski, J; Tota, L; Vicario, P; Weber, AE; Wyvratt, M | 1 |
| Bethke, TD; David, M; Giessmann, T; Hauns, B; Hauschke, D; Hermann, R; Lahu, G; Siegmund, W; Weinbrenner, A; Westphal, K; Zech, K | 1 |
| Brose, M; Bundschuh, DS; Calverley, PM; Fabbri, LM; Izquierdo-Alonso, JL; Martinez, FJ; Rabe, KF | 1 |
| Conti, AA; Dilaghi, B; Modesti, PA; Nozzoli, C | 1 |
| Izquierdo Alonso, JL | 1 |
| Haran, AC; Mansfield, CN; Salmon, M; Sorensen, EA; Tannheimer, SL; Wright, CD | 1 |
| Gupta, S | 1 |
| Basma, H; Fahrid, M; Gunji, Y; Holz, O; Kanaji, N; Liu, X; Magnussen, H; Michalski, J; Muller, KC; Nakanishi, M; Nelson, A; Nogel, S; Rabe, KF; Rennard, SI; Sato, T; Toews, ML; Wang, X | 1 |
| Huang, L; Lai, K; Li, X; Liu, A; Luo, Z; Mao, F; Shan, W; Wang, Z; Xie, J | 1 |
| Chou, A; D'Urzo, AD | 1 |
| Rabe, KF; Suissa, S | 2 |
| Ho, N; Prasad, V; Rho, J | 3 |
| Henry, MT; Hunt, EB; Kennedy, MP; Murphy, DM; Plant, BJ; Worndl, E | 1 |
| Baumlin, N; Campos, M; Dennis, JS; Ivonnet, P; Krick, S; Salathe, M; Schmid, A | 1 |
| Calverley, P; Celli, BR; Chambers, M; Clark, JF; Hawkins, N; Scott, DA; Thompson, JC; Woods, B | 1 |
| Calzetta, L; Cavalli, F; Cazzola, M; Matera, MG; Ora, J; Puxeddu, E; Rogliani, P | 1 |
| Backstrom, J; Brewington, JJ; Clancy, JP; Feldman, A; Kramer, EL; Lu, LJ; Moncivaiz, JD; Ostmann, AJ; Zhu, X | 1 |
3 review(s) available for alpha-aminopyridine and albuterol
| Article | Year |
|---|---|
[New drugs with positive inotropic action].
Topics: Adrenergic beta-Agonists; Albuterol; Aminopyridines; Amrinone; Cardiotonic Agents; Chronic Disease; Ethanolamines; Heart Failure; Humans; Myocardial Contraction; Practolol; Prenalterol; Stimulation, Chemical; Terbutaline | 1982 |
[Clinical profile of roflumilast].
Topics: Adrenal Cortex Hormones; Adrenergic beta-Agonists; Adult; Aged; Albuterol; Aminopyridines; Animals; Anti-Inflammatory Agents, Non-Steroidal; Benzamides; Bronchitis; Bronchodilator Agents; Chronic Disease; Cyclopropanes; Double-Blind Method; Drug Therapy, Combination; Follow-Up Studies; Forced Expiratory Volume; Humans; Mice; Middle Aged; Multicenter Studies as Topic; Muscarinic Antagonists; Phosphodiesterase 4 Inhibitors; Pulmonary Disease, Chronic Obstructive; Randomized Controlled Trials as Topic; Rats; Salmeterol Xinafoate; Scopolamine Derivatives; Tiotropium Bromide; Treatment Outcome; Weight Loss | 2010 |
Mortality and drug therapy in patients with chronic obstructive pulmonary disease: a network meta-analysis.
Topics: Albuterol; Aminopyridines; Beclomethasone; Benzamides; Benzyl Alcohols; Bronchodilator Agents; Budesonide; Chlorobenzenes; Cyclopropanes; Fluticasone-Salmeterol Drug Combination; Formoterol Fumarate; Glucocorticoids; Humans; Indans; Ipratropium; Proportional Hazards Models; Pulmonary Disease, Chronic Obstructive; Quinolones; Survival Rate; Theophylline; Tiotropium Bromide; Triamcinolone | 2015 |
3 trial(s) available for alpha-aminopyridine and albuterol
| Article | Year |
|---|---|
Roflumilast, a once-daily oral phosphodiesterase 4 inhibitor, lacks relevant pharmacokinetic interactions with inhaled salbutamol when co-administered in healthy subjects.
Topics: Adrenergic beta-Agonists; Adult; Albuterol; Aminopyridines; Benzamides; Bronchodilator Agents; Cyclopropanes; Drug Interactions; Humans; Male; Phosphodiesterase Inhibitors | 2006 |
Roflumilast in moderate-to-severe chronic obstructive pulmonary disease treated with longacting bronchodilators: two randomised clinical trials.
Topics: Administration, Inhalation; Administration, Oral; Aged; Albuterol; Aminopyridines; Analysis of Variance; Benzamides; Bronchodilator Agents; Cyclopropanes; Double-Blind Method; Drug Therapy, Combination; Female; Forced Expiratory Volume; Humans; Male; Middle Aged; Phosphodiesterase 4 Inhibitors; Phosphodiesterase Inhibitors; Pulmonary Disease, Chronic Obstructive; Regression Analysis; Salmeterol Xinafoate; Scopolamine Derivatives; Severity of Illness Index; Smoking; Tiotropium Bromide; Treatment Outcome; Vital Capacity | 2009 |
Effect of adding roflumilast or ciclesonide to glycopyrronium on lung volumes and exercise tolerance in patients with severe COPD: A pilot study.
Topics: Administration, Inhalation; Administration, Oral; Aged; Albuterol; Aminopyridines; Benzamides; Cyclopropanes; Drug Therapy, Combination; Exercise Tolerance; Female; Glucocorticoids; Glycopyrrolate; Humans; Lung Volume Measurements; Male; Middle Aged; Muscarinic Antagonists; Phosphodiesterase 4 Inhibitors; Pilot Projects; Pregnenediones; Prospective Studies; Pulmonary Disease, Chronic Obstructive; Severity of Illness Index | 2018 |
16 other study(ies) available for alpha-aminopyridine and albuterol
| Article | Year |
|---|---|
Clinical studies with beta 2 adrenoceptor agonists in heart failure.
Topics: Adrenergic beta-Agonists; Albuterol; Aminopyridines; Amrinone; Cardiotonic Agents; Ethanolamines; Heart Failure; Hemodynamics; Humans; Middle Aged; Myocardial Infarction | 1982 |
L-750355, a human beta3-adrenoceptor agonist; in vitro pharmacology and profile of activity in vivo in the rhesus monkey.
Topics: Adrenergic beta-3 Receptor Agonists; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Albuterol; Aminopyridines; Animals; CHO Cells; Cricetinae; Dose-Response Relationship, Drug; Glycerol; Heart Rate; Humans; Isoproterenol; Lipolysis; Macaca mulatta; Propranolol; Receptors, Adrenergic, beta-1; Sulfonamides; Tachycardia | 2000 |
New evidence in pulmonary and preventive medicine.
Topics: Adrenergic beta-Agonists; Albuterol; Aminopyridines; Benzamides; Breast Neoplasms; Bronchodilator Agents; Cyclopropanes; Disease Progression; Early Detection of Cancer; Evidence-Based Medicine; Female; Humans; Papillomavirus Vaccines; Preventive Medicine; Primary Prevention; Pulmonary Disease, Chronic Obstructive; Salmeterol Xinafoate; Scopolamine Derivatives; Secondary Prevention; Tiotropium Bromide; Uterine Cervical Neoplasms | 2010 |
Additive anti-inflammatory effects of beta 2 adrenoceptor agonists or glucocorticosteroid with roflumilast in human peripheral blood mononuclear cells.
Topics: Adrenergic beta-2 Receptor Agonists; Albuterol; Aminopyridines; Anti-Inflammatory Agents; Benzamides; Cyclopropanes; Dexamethasone; Dose-Response Relationship, Drug; Drug Therapy, Combination; Ethanolamines; Formoterol Fumarate; Glucocorticoids; Humans; Inflammation; Inhibitory Concentration 50; Leukocytes, Mononuclear; Lipopolysaccharides; Male; Phosphodiesterase 4 Inhibitors; Salmeterol Xinafoate; Tumor Necrosis Factor-alpha | 2012 |
Side-effects of roflumilast.
Topics: Albuterol; Aminopyridines; Benzamides; Bronchodilator Agents; Female; Humans; Male; Phosphodiesterase 4 Inhibitors; Phosphodiesterase Inhibitors; Pulmonary Disease, Chronic Obstructive; Scopolamine Derivatives | 2012 |
Attenuation of inhibitory prostaglandin E2 signaling in human lung fibroblasts is mediated by phosphodiesterase 4.
Topics: Adrenergic beta-2 Receptor Agonists; Albuterol; Aminopyridines; Benzamides; Cells, Cultured; Chemotaxis; Colforsin; Cyclic AMP; Cyclic Nucleotide Phosphodiesterases, Type 4; Cyclopropanes; Dinoprostone; Fibroblasts; Fibronectins; Gene Expression; Humans; Iloprost; Isoenzymes; Lung; Phosphodiesterase 4 Inhibitors; Pulmonary Disease, Chronic Obstructive; Receptors, Epoprostenol; Receptors, Prostaglandin; Receptors, Prostaglandin E, EP2 Subtype; Rolipram; Second Messenger Systems | 2012 |
Hybrids consisting of the pharmacophores of salmeterol and roflumilast or phthalazinone: dual β₂-adrenoceptor agonists-PDE4 inhibitors for the treatment of COPD.
Topics: Adrenergic beta-2 Receptor Agonists; Albuterol; Aminopyridines; Benzamides; Bronchodilator Agents; Cyclopropanes; Humans; Phosphodiesterase 4 Inhibitors; Pulmonary Disease, Chronic Obstructive; Salmeterol Xinafoate | 2013 |
New therapy for managing moderate to severe chronic obstructive pulmonary disease.
Topics: Adrenergic beta-2 Receptor Agonists; Albuterol; Aminopyridines; Benzamides; Bronchodilator Agents; Cyclopropanes; Drug Therapy, Combination; Forced Expiratory Volume; Humans; Multicenter Studies as Topic; Phosphodiesterase 4 Inhibitors; Pulmonary Disease, Chronic Obstructive; Randomized Controlled Trials as Topic; Salmeterol Xinafoate; Scopolamine Derivatives; Severity of Illness Index; Tiotropium Bromide | 2014 |
Point: were industry-sponsored roflumilast trials appropriate? Yes.
Topics: Albuterol; Aminopyridines; Anti-Inflammatory Agents; Benzamides; Bronchodilator Agents; Female; Humans; Male; Phosphodiesterase 4 Inhibitors; Phosphodiesterase Inhibitors; Pulmonary Disease, Chronic Obstructive; Scopolamine Derivatives | 2014 |
Counterpoint: were industry-sponsored roflumilast trials appropriate? No.
Topics: Albuterol; Aminopyridines; Anti-Inflammatory Agents; Benzamides; Bronchodilator Agents; Female; Humans; Male; Phosphodiesterase 4 Inhibitors; Phosphodiesterase Inhibitors; Pulmonary Disease, Chronic Obstructive; Scopolamine Derivatives | 2014 |
Rebuttal from Drs Suissa and Rabe.
Topics: Albuterol; Aminopyridines; Anti-Inflammatory Agents; Benzamides; Bronchodilator Agents; Female; Humans; Male; Phosphodiesterase 4 Inhibitors; Phosphodiesterase Inhibitors; Pulmonary Disease, Chronic Obstructive; Scopolamine Derivatives | 2014 |
Rebuttal from Dr Rho et al.
Topics: Albuterol; Aminopyridines; Anti-Inflammatory Agents; Benzamides; Bronchodilator Agents; Female; Humans; Male; Phosphodiesterase 4 Inhibitors; Phosphodiesterase Inhibitors; Pulmonary Disease, Chronic Obstructive; Scopolamine Derivatives | 2014 |
Roflumilast in COPD.
Topics: Albuterol; Aminopyridines; Anti-Inflammatory Agents; Benzamides; Bronchodilator Agents; Female; Humans; Male; Phosphodiesterase 4 Inhibitors; Phosphodiesterase Inhibitors; Pulmonary Disease, Chronic Obstructive; Scopolamine Derivatives | 2015 |
Response.
Topics: Albuterol; Aminopyridines; Anti-Inflammatory Agents; Benzamides; Bronchodilator Agents; Female; Humans; Male; Phosphodiesterase 4 Inhibitors; Phosphodiesterase Inhibitors; Pulmonary Disease, Chronic Obstructive; Scopolamine Derivatives | 2015 |
Roflumilast partially reverses smoke-induced mucociliary dysfunction.
Topics: Albuterol; Aminopyridines; Benzamides; Biosensing Techniques; Bronchi; Cells, Cultured; Chlorides; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Cyclopropanes; Cystic Fibrosis Transmembrane Conductance Regulator; Epithelial Cells; Fluorescence Resonance Energy Transfer; Formoterol Fumarate; Humans; Mucociliary Clearance; Phosphodiesterase 4 Inhibitors; RNA, Messenger; Second Messenger Systems; Smoke; Smoking; Time Factors; Transfection | 2015 |
Chronic β2AR stimulation limits CFTR activation in human airway epithelia.
Topics: Adrenergic beta-2 Receptor Agonists; Albuterol; Aminophenols; Aminopyridines; Benzodioxoles; Cell Line; Cilia; Cyclic AMP; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Drug Interactions; Epithelial Cells; Humans; Mutation; Quinolones; Respiratory Mucosa; Time Factors | 2018 |